ALEXANDER OKSCHE,JOHN STRANG,KEVIN SMITH,LUCIE HELENE JEANNE MOTTIER,STEPHEN HARRIS
申请号：
BR112013029126
公开号：
BR112013029126A2
申请日:
2012.05.11
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract the present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to = 0.5 mg naloxone hcl dissolved in an application fluid of a volume of = 250 µl. furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and / or at least one symptom thereof. patent translation: "intranasal pharmaceutical dosage forms comprising naloxone". The present invention relates to an intranasal pharmaceutical dosage form comprising a dosage unit comprising naloxone or a pharmaceutically acceptable salt thereof in an equivalent amount = 0.5 mg hcl naloxone dissolved in a one volume delivery fluid. = 250 µl. further, the present invention relates to such intranasal pharmaceutical dosage form for use in treating opioid overdose and / or at least one symptom thereof.abstract the present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to = 0.5 mg naloxone hcl dissolved in an application fluid of a volume of = 250 µl. furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof. tradução do resumo resumo patente de invenção: "formas de dosagem farmacêuticas intranasais compreendendo naloxona". a presente invenção refere-se a uma forma de dosagem farmacêutica intranasal compreendendo uma unidade de dosagem compreendendo naloxona ou um sal farmaceuticamente aceitável da mesma em uma quantidade de equivalente = 0,5 mg de hcl de naloxona dissolvido em um fluido de aplicação de um volume = 250 µl. ainda, a presente invenção refere-se a tal forma de dosagem farmacêutica intranasal para uso no tratamento de superdosagem de opioide e/ou pelo menos um
